Skin Conditioning
HUMAN UMBILICAL CORD VESICLES
Safety score · 0–100
Caution
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
Vesicles from human umbilical cord tissue — sits firmly in biologic-drug territory in multiple markets, and is a poor fit for mainstream cosmetics.
Umbilical cord vesicle preparations are derived from post-birth human umbilical tissue, the same material that is otherwise handled under tissue-bank regulations. In the US, the FDA has taken enforcement action against unapproved umbilical MSC products as unlicensed biologic drugs; EU and Asian regulators place similar restrictions on human-derived cosmetic ingredients. There is no CIR or SCCS cosmetic monograph. Cosmetic supply chains do not reliably enforce tissue-bank-grade donor screening, infectious-disease testing, or chain-of-custody, which is the dominant safety concern alongside ethical and consent questions. Alternatives such as plant-derived vesicles should be strongly preferred.
Function
Skin benefits
- Claimed regenerative signaling
Known concerns
- Restricted/prohibited in several major markets
- Infectious-disease transmission risk without tissue-bank controls
- No cosmetic safety review
- Serious ethical and consent issues
- Minimal independent efficacy data
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related skin conditionings
Check your shelf
Find HUMAN UMBILICAL CORD VESICLES in your products.
Scan any cosmetic product with LuxSense to see if it contains HUMAN UMBILICAL CORD VESICLES and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.